quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:00:00·48d
PRRelease
Labcorp Holdings Inc. logo
Lumexa Imaging Holdings Inc. logo
Middleby Corporation logo
+1

Middleby Appoints Glenn Eisenberg To Board of Directors

LH· Labcorp Holdings Inc.LMRI· Lumexa Imaging Holdings Inc.MIDD· Middleby CorporationSOLV· Solventum Corporation
Health CareIndustrials
Original source

Companies

  • LH
    Labcorp Holdings Inc.
    Health Care
  • LMRI
    Lumexa Imaging Holdings Inc.
    Health Care
  • MIDD
    Middleby Corporation
    Industrials
  • SOLV
    Solventum Corporation
    Health Care

Recent analyst ratings

  • Mar 24SOLVUpdateRothschild & Co Redburn$60.00
  • Feb 9LMRIUpdateRaymond James$23.00
  • Jan 26SOLVUpdateKeyBanc Capital Markets$97.00
  • Jan 20SOLVUpdateMizuho$100.00
  • Jan 5LMRIUpdateAnalyst$23.00
  • Jan 5LMRIUpdateJefferies$23.00

Related

  • PR1d
    Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA®
  • PR1d
    Middleby to Host Investor Day on May 12, 2026, Ahead of Business Separation
  • PR3d
    Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer
  • PR8d
    Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes
  • PR9d
    Solventum to Report First Quarter Fiscal 2026 Earnings on May 5, 2026
  • PR9d
    Labcorp Introduces AI-Powered Real-World Data Platform with AWS and Datavant to Accelerate Alzheimer's Research
  • SEC13d
    SEC Form DEFA14A filed by Labcorp Holdings Inc.
  • SEC13d
    SEC Form DEF 14A filed by Labcorp Holdings Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022